Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial: International Journal of Endocrinology

J. B. Ernst, A. Tomaschitz, M.R. Grubler, M. Gaksch, K. Kienreich, N. Verheyen, W. Marz, S. Pilz, A. Zittermann

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Epidemiological evidence suggests that circulating 25-hydroxyvitamin D (25OHD) levels are inversely associated with hemoglobin (Hb) levels and anemia risk. We evaluated whether vitamin D supplementation improves Hb levels and reduces anemia risk in hypertensive patients. Two hundred patients with 25OHD levels 50 nmol/L. Themean (95% confidence interval) vitamin D effect on Hb levels was 0.04 (-0.14 to 0.22) g/dL (P = 0.661). Moreover, vitamin D treatment did not influence anemic status significantly (P > 0.999). Likewise, vitamin D had no significant effect on Hb levels in the subgroups of anemic patients or in patients with initial 25OHD levels
Original languageEnglish
Article number6836402
Number of pages7
JournalInternational Journal of Endocrinology
DOIs
Publication statusPublished - 2016

Cite this

Ernst, J. B. ; Tomaschitz, A. ; Grubler, M.R. ; Gaksch, M. ; Kienreich, K. ; Verheyen, N. ; Marz, W. ; Pilz, S. ; Zittermann, A. / Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial : International Journal of Endocrinology. In: International Journal of Endocrinology. 2016.
@article{a40b0acc8dc3421b8cb06800d4f8b007,
title = "Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial: International Journal of Endocrinology",
abstract = "Epidemiological evidence suggests that circulating 25-hydroxyvitamin D (25OHD) levels are inversely associated with hemoglobin (Hb) levels and anemia risk. We evaluated whether vitamin D supplementation improves Hb levels and reduces anemia risk in hypertensive patients. Two hundred patients with 25OHD levels 50 nmol/L. Themean (95{\%} confidence interval) vitamin D effect on Hb levels was 0.04 (-0.14 to 0.22) g/dL (P = 0.661). Moreover, vitamin D treatment did not influence anemic status significantly (P > 0.999). Likewise, vitamin D had no significant effect on Hb levels in the subgroups of anemic patients or in patients with initial 25OHD levels",
author = "Ernst, {J. B.} and A. Tomaschitz and M.R. Grubler and M. Gaksch and K. Kienreich and N. Verheyen and W. Marz and S. Pilz and A. Zittermann",
note = "ISI Document Delivery No.: DF6TD Times Cited: 0 Cited Reference Count: 39 Ernst, Jana B. Tomaschitz, Andreas Gruebler, Martin R. Gaksch, Martin Kienreich, Katharina Verheyen, Nicolas Maerz, Winfried Pilz, Stefan Zittermann, Armin Grubler, Martin R./0000-0002-1761-2914 0 6 8 HINDAWI PUBLISHING CORP NEW YORK INT J ENDOCRINOL",
year = "2016",
doi = "10.1155/2016/6836402",
language = "English",
journal = "International Journal of Endocrinology",
issn = "1687-8337",
publisher = "Hindawi Publishing Corporation",

}

Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial : International Journal of Endocrinology. / Ernst, J. B.; Tomaschitz, A.; Grubler, M.R.; Gaksch, M.; Kienreich, K.; Verheyen, N.; Marz, W.; Pilz, S.; Zittermann, A.

In: International Journal of Endocrinology, 2016.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial

T2 - International Journal of Endocrinology

AU - Ernst, J. B.

AU - Tomaschitz, A.

AU - Grubler, M.R.

AU - Gaksch, M.

AU - Kienreich, K.

AU - Verheyen, N.

AU - Marz, W.

AU - Pilz, S.

AU - Zittermann, A.

N1 - ISI Document Delivery No.: DF6TD Times Cited: 0 Cited Reference Count: 39 Ernst, Jana B. Tomaschitz, Andreas Gruebler, Martin R. Gaksch, Martin Kienreich, Katharina Verheyen, Nicolas Maerz, Winfried Pilz, Stefan Zittermann, Armin Grubler, Martin R./0000-0002-1761-2914 0 6 8 HINDAWI PUBLISHING CORP NEW YORK INT J ENDOCRINOL

PY - 2016

Y1 - 2016

N2 - Epidemiological evidence suggests that circulating 25-hydroxyvitamin D (25OHD) levels are inversely associated with hemoglobin (Hb) levels and anemia risk. We evaluated whether vitamin D supplementation improves Hb levels and reduces anemia risk in hypertensive patients. Two hundred patients with 25OHD levels 50 nmol/L. Themean (95% confidence interval) vitamin D effect on Hb levels was 0.04 (-0.14 to 0.22) g/dL (P = 0.661). Moreover, vitamin D treatment did not influence anemic status significantly (P > 0.999). Likewise, vitamin D had no significant effect on Hb levels in the subgroups of anemic patients or in patients with initial 25OHD levels

AB - Epidemiological evidence suggests that circulating 25-hydroxyvitamin D (25OHD) levels are inversely associated with hemoglobin (Hb) levels and anemia risk. We evaluated whether vitamin D supplementation improves Hb levels and reduces anemia risk in hypertensive patients. Two hundred patients with 25OHD levels 50 nmol/L. Themean (95% confidence interval) vitamin D effect on Hb levels was 0.04 (-0.14 to 0.22) g/dL (P = 0.661). Moreover, vitamin D treatment did not influence anemic status significantly (P > 0.999). Likewise, vitamin D had no significant effect on Hb levels in the subgroups of anemic patients or in patients with initial 25OHD levels

U2 - 10.1155/2016/6836402

DO - 10.1155/2016/6836402

M3 - Article

JO - International Journal of Endocrinology

JF - International Journal of Endocrinology

SN - 1687-8337

M1 - 6836402

ER -